Nanotherapy is a branch of nanomedicine that involves using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process known as targeting.
Scope of the Report:
This report studies the Nano Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nano Therapy market by product type and applications/end industries.
Much of the research in nanotherapy has been largely directed towards cancer therapy. One of the biggest issues with conventional methods is that as the drug product is distributed throughout the body, both healthy and unhealthy (cancerous cells) are affected, which in turn affects the effectiveness of cancer treatment. It is for this very reason that most cancer patients tend to be hesitant when it comes to chemotherapy. However, nanotherapy, which is also referred to as targeted therapy, offers to deliver the molecules to the affected cells in order to help treat the disease without causing other negative effects to the healthy cells.
The global Nano Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nano Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Nanoprobes
Nanospectra Biosciences
Parvus Therapeutics
Smith And Nephew
Selecta Biosciences
Sirnaomics
Tarveda Therapeutics
Sirnaomics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nanomaterial And Biological Device
Nano Electronic Biosensor
Molecular Nanotechnology
Implantable Cardioverter-Defibrillators
Market Segment by Applications, can be divided into
Cardiovascular Disease
Cancer Therapy
Diabetes Treatment
Rheumatoid Arthritis
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Nano Therapy Market Overview
1.1 Product Overview and Scope of Nano Therapy
1.2 Classification of Nano Therapy by Types
1.2.1 Global Nano Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Nano Therapy Revenue Market Share by Types in 2017
1.2.3 Nanomaterial And Biological Device
1.2.4 Nano Electronic Biosensor
1.2.5 Molecular Nanotechnology
1.2.6 Implantable Cardioverter-Defibrillators
1.3 Global Nano Therapy Market by Application
1.3.1 Global Nano Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cardiovascular Disease
1.3.3 Cancer Therapy
1.3.4 Diabetes Treatment
1.3.5 Rheumatoid Arthritis
1.4 Global Nano Therapy Market by Regions
1.4.1 Global Nano Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Nano Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nano Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nano Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Nano Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nano Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Nano Therapy (2013-2023)
2 Manufacturers Profiles
2.1 Nanoprobes
2.1.1 Business Overview
2.1.2 Nano Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nanoprobes Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Nanospectra Biosciences
2.2.1 Business Overview
2.2.2 Nano Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Nanospectra Biosciences Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Parvus Therapeutics
2.3.1 Business Overview
2.3.2 Nano Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Parvus Therapeutics Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Smith And Nephew
2.4.1 Business Overview
2.4.2 Nano Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Smith And Nephew Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Selecta Biosciences
2.5.1 Business Overview
2.5.2 Nano Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Selecta Biosciences Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sirnaomics
2.6.1 Business Overview
2.6.2 Nano Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sirnaomics Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Tarveda Therapeutics
2.7.1 Business Overview
2.7.2 Nano Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tarveda Therapeutics Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sirnaomics
2.8.1 Business Overview
2.8.2 Nano Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sirnaomics Nano Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nano Therapy Market Competition, by Players
3.1 Global Nano Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Nano Therapy Players Market Share
3.2.2 Top 10 Nano Therapy Players Market Share
3.3 Market Competition Trend
4 Global Nano Therapy Market Size by Regions
4.1 Global Nano Therapy Revenue and Market Share by Regions
4.2 North America Nano Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Nano Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nano Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Nano Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nano Therapy Revenue and Growth Rate (2013-2018)
5 North America Nano Therapy Revenue by Countries
5.1 North America Nano Therapy Revenue by Countries (2013-2018)
5.2 USA Nano Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Nano Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Nano Therapy Revenue and Growth Rate (2013-2018)
6 Europe Nano Therapy Revenue by Countries
6.1 Europe Nano Therapy Revenue by Countries (2013-2018)
6.2 Germany Nano Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Nano Therapy Revenue and Growth Rate (2013-2018)
6.4 France Nano Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Nano Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Nano Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Nano Therapy Revenue by Countries
7.1 Asia-Pacific Nano Therapy Revenue by Countries (2013-2018)
7.2 China Nano Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Nano Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Nano Therapy Revenue and Growth Rate (2013-2018)
7.5 India Nano Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Nano Therapy Revenue and Growth Rate (2013-2018)
8 South America Nano Therapy Revenue by Countries
8.1 South America Nano Therapy Revenue by Countries (2013-2018)
8.2 Brazil Nano Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Nano Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Nano Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Nano Therapy by Countries
9.1 Middle East and Africa Nano Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Nano Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Nano Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Nano Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Nano Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Nano Therapy Revenue and Growth Rate (2013-2018)
10 Global Nano Therapy Market Segment by Type
10.1 Global Nano Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Nano Therapy Market Forecast by Type (2018-2023)
10.3 Nanomaterial And Biological Device Revenue Growth Rate (2013-2023)
10.4 Nano Electronic Biosensor Revenue Growth Rate (2013-2023)
10.5 Molecular Nanotechnology Revenue Growth Rate (2013-2023)
10.6 Implantable Cardioverter-Defibrillators Revenue Growth Rate (2013-2023)
11 Global Nano Therapy Market Segment by Application
11.1 Global Nano Therapy Revenue Market Share by Application (2013-2018)
11.2 Nano Therapy Market Forecast by Application (2018-2023)
11.3 Cardiovascular Disease Revenue Growth (2013-2018)
11.4 Cancer Therapy Revenue Growth (2013-2018)
11.5 Diabetes Treatment Revenue Growth (2013-2018)
11.6 Rheumatoid Arthritis Revenue Growth (2013-2018)
12 Global Nano Therapy Market Size Forecast (2018-2023)
12.1 Global Nano Therapy Market Size Forecast (2018-2023)
12.2 Global Nano Therapy Market Forecast by Regions (2018-2023)
12.3 North America Nano Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Nano Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Nano Therapy Revenue Market Forecast (2018-2023)
12.6 South America Nano Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Nano Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Nano Therapy Picture
Table Product Specifications of Nano Therapy
Table Global Nano Therapy and Revenue (Million USD) Market Split by Product Type
Figur